Skip to main content
Download PDF

Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation

BMC Cancer volume 23, Article number: 588 (2023) Cite this article

Abstract

Purpose

To discuss the dosimetric advantages and reliability of the accurate delivery of online adaptive radiotherapy(online ART) for uterine cervical cancer(UCC).

Methods and materials

Six UCC patients were enrolled in this study. 95% of the planning target volume (PTV) reached 100% of the prescription dose (50.4 Gy/28fractions/6weeks) was required. The patients were scanned with uRT-Linac 506c KV-FBCT then the target volume (TV) and organs at risk (OARs) were delineated by doctors. The dosimeters designed and obtained a routine plan (Plan0). KV-FBCT was used for image guidance before subsequent fractional treatment. The online ART was processed after registration, which acquired a virtual nonadaptive radiotherapy plan (VPlan) and an adaptive plan (APlan). VPlan was the direct calculation of Plan0 on the fractional image, while APlan required adaptive optimization and calculation. In vivo dose monitoring and three-dimensional dose reconstruction were required during the implementation of APlan.

Results

The inter-fractional volumes of the bladder and rectum changed greatly among the treatments. These changes influenced the primary gross tumor volume (GTVp) and the position deviation of GTVp and PTV and positively affected the prescription dose coverage of TV. GTVp decreased gradually along with dose accumulation. The Dmax, D98, D95, D50, and D2 of APlan were superior to those of VPlan in target dose distribution. APlan had good conformal index, homogeneity index and target coverage. The rectum V40 and Dmax, bladder V40, the small bowel V40 and Dmax of APlan were better than that of VPlan. The APlan’s fractional mean γ passing rate was significantly higher than the international standard and the mean γ passing rate of all cases after the three-dimensional reconstruction was higher than 97.0%.

Conclusion

Online ART in external radiotherapy of UCC significantly improved the dose distribution and can become an ideal technology to achieve individualized precise radiotherapy.

Peer Review reports

Introduction

Uterine cervical cancer (UCC) is the most common gynecological malignant tumor worldwide. Radiotherapy is applicable to all stages of UCC and is a radical treatment for locally advanced UCC and an auxiliary treatment for early- and middle -stage UCC with postoperative risk factors. With the application of intensity-modulated technology which represents precise radiotherapy, the radical rate of UCC has increased from approximately 40–70% in clinical practice and the toxicity and side effects have also been significantly reduced [1,2,3]. UCC radiotherapy includes external beam radiotherapy (EBRT), brachytherapy (BT) and their combination. EBRT plays an important role in the treatment of UCC, whose accuracy of dose delivery directly affects the final efficacy [4]. At present, multimodal image fusion improved accuracy of target area delineation, and image-guided technique significantly reduces systematic errors, such as set-up errors [5, 6]. However, due to the special anatomical position of the cervix, adjacent to the bladder and rectum with obvious changes in physiological status (varying due to the degree of filling), coupled with random factors such as tumor retraction, the target area may be deformed and moved between fractional treatments, which may lead to dose distribution deviation [7, 8]. Normally, the above impacts might be reduced by trying to complete positioning, planning and treatment under a relatively stable physiological state within half an hour because the anatomical morphology of the bladder and rectum does not change significantly [9,10,11,12].

Online adaptive radiotherapy (online ART) can modify plans based on real-time images and can be executed immediately to accommodate random transfer of target volume (TV) and organs, as well as the deformation of organs at risk (OARs) in the fractional treatments, to ensure the coverage of the target dose and to control the dose of OARs [13,14,15]. Online ART is particularly suitable for stereotactic radiotherapy of abdominal and pelvic tumors [16,17,18,19,20,21]. Online ART, offline ART and real-time ART are collectively known as adaptive radiotherapy (ART), of which the plan can be dynamically modified according to the anatomical and/or physiological changes of the patient, rather than maintaining a static plan throughout the treatment process, to ensure dose targeting [22,23,24,25]. Offline ART mainly targets systematic and progressive changes during treatment, such as patient weight loss and tumor morphologic changes. The new plan will be adopted in the follow-up fractional treatment. Offline ART has a significant effect on the clinical efficacy of head and neck and lung tumors [26,27,28,29,30]. Real-time ART can automatically modify and implement plans through continuous imaging, replanning and rapid dose calculation during treatment to reduce the impact caused by respiration, internal state changes and organ peristalsis or pulsation and achieve targeted tracking irradiation [31,32,33,34]. The concept of ART was put forward in 1990s and offline ART has obtained certain positive research results [26,27,28,29,30, 35, 36]. However, online ART and real-time ART are limited by technical conditions and other factors, so far their clinical applications are few.

This study conducted online ART for UCC based on daily CT images. We aimed to discuss the necessity of online ART for UCC by analyzing the volume changes of the bladder and rectum, the change rules of primary gross tumor volume (GTVp) and the planning target volume (PTV), and the relative deviation of the target geometric center before each treatment. By comparing the online adaptive plan with the virtual nonadaptive radiotherapy (V-non ART) plan, the dosimetric results and influencing factors of the online ART plan were analyzed, of which the dosimetric advantages were discussed to lay a foundation for adjusting the external boundary from the clinical target volume (CTV) to the PTV and the prescription dose segmentation method. The accuracy of dose delivery was confirmed by the statistical results of in vivo dose monitoring. Finally, our study will provide data support for the clinical promotion of online ART in the treatment of UCC.

Materials and methods

Clinical materials

Six uterine cervical cancer patients with EBRT indications in our department from March 2022 to May 2022 were included in this study. Three patients received postoperative radiotherapy and three patients received external radiotherapy before BT or surgery. Patients did not need para-aortic irradiation, did not have indwelling urinary catheter and can persist in lying flat for more than 30 min. The median age was 54.5 years old and the functional status score (Karnofsky, KPS) was greater than 90.

Equipment

The uRT-linac 506c (United Imaging Healthcare Co., Ltd., Shanghai, China) is a CT-integrated linac guided by high-definition images, which was certified by China Food and Drug Administration(CFDA) as a radiotherapy device for treating systemic lesions in 2018. The uRT-linac 506c and radiotherapy plan management system (uRT-TPOIS, R001) integrate kilovoltage fan beam computed tomography (KV-FBCT) and a 6 MV X-ray linac, which are coaxial in the same bed, simultaneously realizing KV-FBCT image positioning and image guidance. The quality of the obtained image is consistent with the positioning image, which can be directly used for planning. The treatment planning system(TPS) has the functions of image fusion, automatic sketching, automatic planning, deformation and rigid registration and provides planning design methods, including 3-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), volume-modulated arc therapy (VMAT) and stereotactic body radiation therapy (SBRT), which support online ART.

Patient model and plan preparation

Patients were instructed to empty their bladders and rectums 2 h before CT localization and treatments and to drink 500 mL water 1 h in advance. KV-FBCT positioning scanning and image-guided scanning of uRT-linac 506c were adopted, with the abdominal helical scanning protocol. The scanning scope included the lower abdomen and pelvis, with a thickness of 5 mm. Seven beams (gantry angle: 180°, 130°, 80°, 30°, 330°, 280° and 230°; collimator angle: 0°; maximum dose rate 600 MU/min) of coplanar dIMRT were used. 95% PTV received 100% of the prescription dose (50.4 Gy/28 fractions/6 weeks) [37, 38]. The region of interest (ROI) template (naming and structural relationship processing of TV and OARs to be sketched), the optimized constraint template and the clinical goal sheet template were prepared (Table S1). The gross tumor volume of lymph node (GTVn) and the GTVp were treated with late-course incremental radiotherapy, which was not included in this study.

Conventional radiotherapy plan formulation

KV-FBCT was used for localization scanning after effectively fixing the patient’s position, and the target area was then delineated according to the guidelines of the Radiation Therapy Oncology Group and the relevant international consensus [38,39,40,41,42]. GTVp refers to the primary lesion of cervical tumors. GTVn refers to pelvic metastatic lymph nodes. CTV generally includes vaginal stumps, common iliac, internal iliac, external iliac, obturator and presacral lymphatic drainage areas (non surgical cases also include GTV, cervix, uterine body, parauterine and partial vagina). PTV was formed by the expansion of CTV by 7–15 mm. The corresponding beam template and optimized constraint template were loaded for plan design and optimizing calculation. Finally, the conventional plan, named Plan0, was obtained. Plan0 was transplanted to the phantom for point and surface dose verification and it entered the treatment phase after passing the verification.

Formulation of the online ART and V-non-ART plans

After the first reset of the patient, KV-FBCT image guidance was performed according to the preset scanning template. The positioning error was corrected under registration with the Plan0 image and then the online ART workflow was initiated, entering the patient’s intelligent planning module in the TPS and entering the online ART workflow after automatically loading Plan0. The OARs and couch in Plan0 were automatically delineated by deformation and target volumes (CTV and/or GTVp) in Plan0 were rigidly mapped to the current image and manually modified according to the Plan0 target area delineation principle. After confirming the ROI, an adaptive optimized calculation was selected based on Plan0 to generate the current adaptive radiotherapy plan APlanX (X = 1 ~ 28) according to the modified target area. The adaptive optimization algorithm used the dose distribution of Plan0 and the clinical goal sheet as inputs. The clinical goal sheet contained a wish-list with priorities, which was used to explicit the demands for prescription dose coverage of planning target and dosimetric criteria of OARs. The priorities were set to 1, 2 and 3, in which the number 1 represented the highest priority, and the number 3 represented the least priority (more details in supplementary material). Aplan was evaluated and then transmitted to treatment delivery application (TDA) for implementation once the dosimetric parameters of the ROI reached the pre-set dose objectives. In addition, the direct calculation was selected, and Plan0 was mapped to the current image, which further obtained the current virtual nonadaptive radiotherapy plan VPlanX (X = 1 ~ 28).

Implementation of APlan and in vivo dose monitoring

An electronic portal imaging device (EPID) was used to monitor the in vivo doses of radiation fields. If the global γ passing rate was lower than 88% under the 3%/3mm benchmark, the current treatment was suspended or terminated, and the reasons were recorded and analyzed. The three-dimensional dose reconstruction was finally compared with the planned value.

Statistical comparison of APlan- and VPlan-related parameters

The volume changes in the bladder and rectum were analyzed by comparing APlan and Plan0; the relative volume changes in the bladder, rectum, GTVp and PTV were calculated by the V (APlan-Plan0)/VPlan0 volume normalization method. [APlan offset value (x’, y’, z’) - Plan0 offset value (x, y, z)] and \(\sqrt{{({\text{x}}^{{\prime }} - \text{x})}^{2}+{({\text{y}}^{{\prime }}-\text{y})}^{2}+{({\text{z}}^{{\prime }}-\text{z})}^{2}}\) were used to describe the deviation changes in the relative positions of the geometric center of the PTV and the GTVp. The dosimetric differences between the TV and OARs were observed by comparing APlan and VPlan.

Statistical methods

SPSS 25.0 was used to perform statistical analysis on dosimetric parameters of TV and OARs, expressed by mean ± standard deviation. The Shapiro‒Wilk method was used to test the normality of the data. A paired sample t test was performed for data lines with a normal distribution, while the Wilcoxon signed rank test was performed with a significance level of 0.05.

Results

Volume changes of the bladder and rectum and volume change and position deviation of the PTV and the GTVp

As shown in Fig. 1(a) and Fig. 1(b), the volumes of the bladder and rectum in 6 cases changed significantly among fractional treatments, especially the bladder, but all cases were irregular. For example, the bladder volume in the second fraction of case 6 had the most obvious change with respect to Plan0, reaching 4.06, which is shown in Fig. 1(c), and the overfilled bladder was found in this division; the rectal volume of the fourth fraction of case 2 had the largest difference with respect to Plan0, which was approximately 2.17, as shown in Fig. 1(d), suggesting rectal inflation with the image analysis.

Fig. 1
figure 1

Relative changes in OARs, GTVp and PTV in patients. (a) Relative changes in bladder volume in each fraction. (b) Relative changes in rectum volume in each fraction. (c) Images of the initial and second treatments in case 6 (Top row: initial images. Middle row: daily images. Bottom row: merged images). (d) Images of the initial and fourth treatments in case 2 (Top row: initial images. Middle row: daily images. Bottom row: merged images). (e) Relative volume changes in the bladder, rectum, PTV and GTVp in each patient. (f) Effect of bladder and rectum volume changes on target volume deviation

Full size image

As shown in Fig. 1(e), the change of bladder volume was more obvious than that of the rectum, which was consistent with Fig. 1(a) and Fig. 1(b); the PTV and GTVp did not change significantly, but the GTVp decreased gradually with the accumulation of dose; the relative deviation changes of the geometric center point and “setup” point of the PTV and the GTVp in the lateral (LAT/X), vertical(VRT/Y) and longitudinal(LNG/Z) directions were obvious (the deviation ranges in the X, Y, and Z directions were -0.45~0.29 cm, -0.49~0.57 cm, -0.82~0.76 cm and -0.69~0.62 cm, -0.88~1.26 cm, -0.96~0.88 cm, respectively). As shown in Fig. 1(f), this deviation was affected by the volume changes of the bladder and rectum. The offset value was close to 0 when the volume changes of the bladder and rectum were small, and the points with large changes in the offset value had corresponding large changes in the bladder and rectum volume.

Statistical results of dosimetric parameters

In terms of target dose distribution, as shown in Table 1, Dmax, D98, D95, D50 and D2 of APlan were superior to those of VPlan, with significant differences (p < 0.05), among which the D95 (5041.18 ± 42.02) of APlan met the prescription requirements, while D95 (4972.67 ± 159.17) of VPlan failed to meet the prescription requirements. Figure 2(a) also shows that the D95 of APlan reached 100% of the prescription dose, while most implementations of VPlan did not; APlan had good conformal index (CI = 0.92 ± 0.02), homogeneity index (HI = 0.05 ± 0.00) and target coverage (V100%=0.96 ± 0.01), while VPlan had significant differences with its corresponding parameters (0.82 ± 0.06, 0.10 ± 0.06, 0.90 ± 0.04, respectively) (p < 0.05).

Table 1 Comparison of dosimetric parameters of various planning target volumes
Full size table
Fig. 2
figure 2

Dosage comparison between virtual planning (VPlan) and adaptive planning (APlan). (a) Doses of 95%PTV received in the two plans. (b) Bladder coverage with 40 Gy in the two plans. (c) Rectum coverage with 40 Gy in the two plans. (d) Dose volume histograms of one patient of the three plans

Full size image

The protection of OARs is shown in Table 2. The rectum V40 (13.42 ± 7.88) and bladder V40 (24.75 ± 7.63) of APlan were superior to the rectum V40 (15.91 ± 12.87) and bladder V40 (24.01 ± 14.66) of VPlan. The small bowel Dmax, V40 and rectum Dmax of APlan were better than those of VPlan (p < 0.05). Other parameters were equivalent. Figure 2(b) and Fig. 2(c) show the doses of bladder V40 and rectum V40 in 168 fractions of 6 patients, which suggested that the bladder V40 and rectum V40 of APlan were better than those of VPlan, but without statistical significance.

Table 2 Comparison of dosimetric parameters of various organs at risk
Full size table

The dose volume histogram (DVH) in Fig. 2(d) intuitively shows that the dosimetric characteristics of APlan are equivalent to those of Plan0 and superior to those of VPlan.

Relative relationship between target dose and volume changes in the bladder and rectum

As shown in Fig. 3(a), the relative change in the VPlan target dose was positively related to the volume changes in the bladder and rectum, which directly affected the target dose distribution. Figure 3(b ~ d) shows the dose distribution in the target area under three different conditions (rectal volume reduction, GTVp reduction and rectal enlargement due to inflation). It was found that the target moved backward due to rectal volume reduction, and a low-dose area appeared in VPlan (Fig. 3(b)), while it was suggested in Fig. 3(c) that CTV (PTV) decreased due to GTVp shrinking and uterine body sinking, and the irradiated volumes of normal tissues and organs in VPlan were too large. Furthermore, Fig. 3(d) suggested that the rectal volume increased due to inflation and expansion, entering into the original treatment area in VPlan, with increasing irradiated dose and volume, which could be avoided by APlan.

Fig. 3
figure 3

Effects of bladder and rectum volume changes on the dose distribution in the target volume. (a) The relationship between the volume changes of bladder and rectum and PTV D95 in VPlan. (b~d) Comparison of dose distribution in the three different plans. Plan0 in the top row, VPlan in the middle row, APlan in the bottom row, where (b) and (c) are the 7th and 28th fractions of a patient; the rectum volume of (b) decreased, and the GTVp of (c) decreased; (d) is the 20th fraction of a patient in whom the rectum was inflated and dilated

Full size image

In vivo dose monitoring and three-dimensional dose reconstruction analysis

As shown in Fig. 4(a ~ c), the 168 fractions’ mean γ passing rate of APlan of 6 cases was significantly higher than the international standard [43, 44]. The mean passing rate of case 6 was slightly lower (97.6%) than others, of which the fractional passing rate was generally greater than 96.5%. The mean passing rates of the other cases were more than 98.5%, and their fractional passing rates were generally greater than 98.0%. The lowest passing rate was from case 4, though it was still close to 95.0%. The statistical results of all angles’ γ passing rate showed that the mean γ passing rate at 280° was approximately 97.5%, which was obviously lower than the other angles.

Fig. 4
figure 4

Dosage monitoring using in vivo method. (a~c) Results of two-dimensional in vivo dose monitoring. (d~f) Dose distribution results of the three-dimensional reconstruction

Full size image

Three-dimensional reconstruction was carried out for the collected two-dimensional dose information, and the mean γ passing rates of each case were slightly lower than the corresponding two-dimensional mean γ passing rates, which were all higher than 97.0%. The dosimetric parameters of the TV and OARs in the three-dimensional reconstruction dose field were not significantly different from those of APlan (Fig. 4(d ~ f)).

Discussion

Uterine cervical cancer (UCC) is a typical disease that is suitable and necessary for ART. It has been noted in UCC radiotherapy practice that tumor shrinkage, the movement and volume changes of peri-cervical OARs between fractions negatively affect the delivery of planned doses, which has the potential to reduce local tumor control and/or increase normal tissue toxicities [13, 45]. Based on IMRT and IGRT, performing the online ART may be the best means to achieve UCC clinical dosimetric goals. In this study, we found significant volume changes in the bladder and rectum relative to localized images through 168 fractional images of 6 cases and more significantly in the bladder, and all were irregular, consistent with other reports in the literature [7, 8, 46]. This may be related to factors such as altered human metabolism, surgery and radiation inflammation [47]. The volume changes of PTV generated by CTV expansion are not obvious, as the anatomy of the pelvis is solid and most of the lymphatic drainage areas in UCC are distributed along the pelvis wall [48]; approximately 80% of UCC cases are squamous cell carcinoma, which is relatively sensitive to radiation, which explains why the GTVp shrinks to different degrees with the accumulation of radiation dose – for example, by 60–80% in the first 3–4 weeks of radiotherapy [49,50,51]. This study also presented similar results. In addition, the volume changes of the bladder and rectum were found to affect the PTV and the GTVp, resulting in changes in the relative offset between the geometric center point and the “setup” point in the three-dimensional direction, and the GTVp was particularly significant in the vertical direction, reaching 2.14 cm. The points with large changes in offset values corresponded to larger changes in bladder and rectal volumes and vice versa.

Online ART has obvious dosimetric advantages in UCC radiotherapy and can deliver dose accurately. With the introduction of the ART concept, offline ART was gradually used in clinical research and practice, especially after the advent of kilovoltage cone beam computed tomography (KV-CBCT). The value of offline ART in adjusting the TV dose distribution and reducing the CTV-PTV border has been proved, and partly reduced the impact of tumor shrinkage to some extent. However, relative to the anatomical information of the thoracoabdominal and pelvic cavities of localization, offline ART cannot cope with the impact of random changes at each fractional treatment [52, 53]. To balance both of these effects, online ART was developed. Due to the technical characteristics and factors such as less fractions of BT for UCC, online ART had been successfully applied in the BT stage of UCC. In the last two decades, the technique has gradually matured and become routine [54,55,56]. Currently, EBRT for UCC is usually performed using coplanar IMRT or VMAT with conventional splitting of dose and 23–28 fractions, which is characterized by multiple fractions and long duration. In recent years, some scholars have randomized a few online ART studies based on CT guidance during the stage of EBRT for UCC, while there has not yet been reported on whole course online ART [57, 58]. EBRT was prescribed at a dose of 50.4 Gy for 28 fractions, five fractions per week, in all 6 cases of this study. Each time, the real-time images were reacquired, the TVs and OARs were redrawn based on the anatomical structure of the image feedback, and finally, the dose was optimized and the treatment was administered, completing the “localization–planning–treatment” regimen while the patient was almost stationary. In each case, 28 groups of APlan and VPlan and 1 group of Plan0 were obtained, reflecting the dosimetric differences between the two radiotherapy modalities. The dose distribution of Plan0 was directly mapped to the adaptive target area to form VPlan, and then the actual received dose of real-time TV and OARs was analyzed, which mainly showed that the target area coverage of the prescribed dose was insufficient, and the small bowel Dmax and rectum Dmax and V40 exceeded the standard or were even higher than the prescribed dose; the dose-optimized calculation was performed for real-time TV and OARs to obtain APlan. Its dosimetric parameters almost all met the standard, which was equivalent to Plan0, achieving a static effect with a dynamic adjustment.

Image quality and deformable alignment accuracy are key elements of Online ART, and device functionality is its foundation. The uRT-Linac 506c used in this study combines a diagnostic-grade KV-FBCT and a 6MV-X linac into a single device with two functions, image positioning and radiotherapy, and is equipped with integrated ART function software. KV-FBCT is guided by the same scan parameters as the positioning CT, and the acquired image sequence shares a CT value-relative electron density conversion curve with the positioning image so it can be used not only for pose calibration but also directly for planning design, which is the key to realizing online ART and is lacking in other forms of modal image guidance (e.g. CBCT, MR). In addition, the mechanical design of the CT and the linac are coaxial, with the same couch and the same coordinate system, and the couch board sinking monitoring and automatic correction function are added to keep the spatial position of the patient constant throughout the whole process. The Demons algorithm is used for variable image alignment, thus ensuring high image quality and high accuracy of alignment [59, 60].

EPID-based in vivo dose monitoring is a reliable guarantee of accurate APlan dose delivery. As the patient was placed on the couch during the whole process of online ART, pretreatment planned dose verification was not possible. Therefore, during the execution of APlan, in vivo dose monitoring was performed using EPID to analyze the γ passing rate in each field in real time and to set thresholds for warnings and interruptions according to the corresponding criteria [43, 44, 61,62,63,64]. The mean γ passing rate of 168 events in this study was significantly higher than the international standard, except for a slightly lower mean γ passing rate in the 280° incidence direction (possibly due to the variation of the equivalent thickness of the transmitted body), and the mean γ passing rates of the remaining angles were above 98.5%. The two-dimensional dose comparison was not sufficient to confirm its accuracy, so a three-dimensional reconstruction was also needed. The reconstructed dose distribution was analyzed by three-dimensional comparison with the planned presented dose distribution. The three-dimensional mean γ passing rates of all cases in this study were higher than 97.0%, indicating that there was no significant change in the anatomical environment of the target area during the process from APlan fractionated image acquisition to execution, and the APlan dose could be delivered accurately with the error controlled within 5% of the expected dose.

Online ART may change the clinical strategy in UCC. The shape and location of GTVp during online ART are largely determined, so simultaneous integrated boost of GTVp, during the EBRT stage, increasing the dose of the primary site, adjusting the dose splitting pattern to shorten the treatment time, all of which have the potential to improve the efficacy. The main driver of target area location shift comes from volume changes in the bladder and rectum. Even if the preparation before each radiotherapy treatment is consistent with that before positioning, the reproducibility of the shape of bladder and rectum cannot be improved or even vary significantly, with the largest relative changes in this study reaching 405.74% and 217.20%, respectively. Thus, online ART helps to omit the cumbersome preparation process, such as filling the bladder and emptying the rectum before positioning and treatment, thus improving patient comfort.

In this research, APlan presented dosimetric results with significant advantages and was accurately implemented. However, due to the small number of cases and the short follow-up period, it is not yet possible to confirm whether the final clinical benefit was achieved. There are still further detailed explorations are needed such as what are the trigger conditions of online ART, what are the principles of target volume adjustment, how to ensure the accuracy of dose accumulation in fading tumors and what are the possible risks of increasing the radiation dose of each KV-FBCT [65, 66]?, etc. All of these questions need to be further considered and studied. In addition, during the whole process of online ART, since patients are always immobilized on the couch, the time of the online ART workflow needs to be shortened as much as possible. Through this study, TV modification and APlan optimization calculations were time-consuming and the total time of online ART was 21 min on average. Therefore, more in-depth research is also needed in developing intelligent registration algorithms and automatic dose optimization algorithms to strive for further optimization and iteration [67].

Conclusions

The application of online adaptive radiotherapy in UCC external radiotherapy can significantly improve the dosimetric distribution of radiotherapy for UCC; dose monitoring during treatment and 3D reconstruction of the dose after treatment can effectively guarantee the correct implementation of online adaptive radiotherapy. Further studies on image quality, deformation alignment and dose optimization algorithms can promote the application of online ART in UCC radiotherapy and may change some clinical strategies of UCC radiotherapy. Online ART has significant dosimetric advantages in UCC radiotherapy and is an ideal technique for achieving individualized and precise radiotherapy, with clinical promotional value.

Data Availability

All data generated or analysed during this study are included in this published article [and its supplementary information files].

Abbreviations

ART:

Adaptive radiotherapy

BT:

Brachytherapy

CBCT:

Cone beam computed tomography

CTV:

Clinical target volume

DVH:

Dose volume histogram

EBRT:

External beam radiotherapy

EPID:

Electronic portal imaging device

FBCT:

Fan beam computed tomography

GTVn:

Gross tumor volume of lymph node

GTVp:

Primary gross tumor volume

IMRT:

Intensity-modulated radiotherapy

OAR:

Organ at risk

PTV:

Planning target volume

ROI:

Region of interest

SBRT:

Stereotactic body radiation therapy

TV:

Target volume

UCC:

Uterine cervical cancer

VMAT:

Volume-modulated arc therapy

References

  1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.

    Article  PubMed  Google Scholar 

  2. Suneja G, Viswanathan A. Gynecologic malignancies. Hematol Oncol Clin North Am. 2020;34(1):71–89.

    Article  PubMed  Google Scholar 

  3. Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):28–44.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Faye MD, Alfieri J. Advances in Radiation Oncology for the treatment of Cervical Cancer. Curr Oncol. 2022;29(2):928–44.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Boda-Heggemann J, Lohr F, Wenz F, et al. kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol. 2011;187(5):284–91.

    Article  PubMed  Google Scholar 

  6. Garibaldi C, Fodor C, Riva G, et al. Cone-beam CT-based inter-fraction localization errors for tumors in the pelvic region. Phys Med. 2018;46:59–66.

    Article  PubMed  Google Scholar 

  7. Eminowicz G, Rompokos V, Stacey C, et al. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer. Radiother Oncol. 2017;122(1):116–21.

    Article  PubMed  Google Scholar 

  8. Chen J, Liu P, Chen W, et al. Early changes of volume and spatial location in target and normal tissues caused by IMRT for cervical cancer. Tumori. 2016;102(6):610–3.

    Article  PubMed  Google Scholar 

  9. Heijkoop ST, Langerak TR, Quint S, et al. Quantification of intra-fraction changes during radiotherapy of cervical cancer assessed with pre- and post-fraction cone Beam CT scans. Radiother Oncol. 2015;117(3):536–41.

    Article  PubMed  Google Scholar 

  10. Shortall J, Vasquez Osorio E, Cree A, et al. Inter- and intra-fractional stability of rectal gas in pelvic cancer patients during MRIgRT. Med Phys. 2021;48(1):414–26.

    Article  CAS  PubMed  Google Scholar 

  11. Li X, Wang L, Cui Z, et al. Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy. Radiat Oncol. 2021;16(1):179.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Luo H, Jin F, Yang D, et al. Interfractional variation in bladder volume and its impact on cervical cancer radiotherapy: clinical significance of portable bladder scanner. Med Phys. 2016;43(7):4412.

    Article  PubMed  Google Scholar 

  13. Lim-Reinders S, Keller BM, Al-Ward S, et al. Online Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017;99(4):994–1003.

    Article  PubMed  Google Scholar 

  14. Kim H, Lee P, Tree AC, et al. Adaptive Radiation Therapy Physician Guidelines: recommendations from an Expert users’ panel. Pract Radiat Oncol. 2022;12(5):e355–62.

    Article  PubMed  Google Scholar 

  15. Kerkmeijer LGW, Valentini V, Fuller CDD, et al. Editorial: online adaptive MR-Guided Radiotherapy. Front Oncol. 2021;11:748685.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Han EY, Wang H, Briere TM, et al. Brain stereotactic radiosurgery using MR-guided online adaptive planning for daily setup variation: an end-to-end test. J Appl Clin Med Phys. 2022;23(3):e13518.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Poon DMC, Yang B, Geng H, et al. Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer. J Cancer Res Clin Oncol. 2022;24:1–10.

    Google Scholar 

  18. Ikushima H, Balter P, Komaki R, et al. Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2011;79(2):473–80.

    Article  PubMed  Google Scholar 

  19. Gong W, Yao Y, Ni J, et al. Deep learning-based low-dose CT for adaptive radiotherapy of abdominal and pelvic tumors. Front Oncol. 2022;12:968537.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kensen CM, Janssen TM, Betgen A, et al. Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer. Radiat Oncol. 2022;17(1):110.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Nierer L, Eze C, da Silva Mendes V, et al. Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate. Radiat Oncol. 2022;17(1):53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yan D, Vicini F, Wong J, et al. Adaptive radiation therapy. Phys Med Biol. 1997;42(1):123–32.

    Article  CAS  PubMed  Google Scholar 

  23. Glide-Hurst CK, Lee P, Yock AD, et al. Adaptive Radiation Therapy (ART) strategies and technical considerations: a state of the ART Review from NRG Oncology. Int J Radiat Oncol Biol Phys. 2021;109(4):1054–75.

    Article  PubMed  Google Scholar 

  24. Yan D. Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol. 2010;20(2):79–83.

    Article  PubMed  Google Scholar 

  25. Chetty IJ, Fontenot J. Adaptive Radiation Therapy: Off-Line, On-Line, and In-Line? Int J Radiat Oncol Biol Phys. 2017;99(3):689–91.

    Article  PubMed  Google Scholar 

  26. Yan D, Liang J. Expected treatment dose construction and adaptive inverse planning optimization: implementation for offline head and neck cancer adaptive radiotherapy. Med Phys. 2013;40(2):021719.

    Article  PubMed  Google Scholar 

  27. Lee VS, SchettIno G, Nisbet A. UK adaptive radiotherapy practices for head and neck cancer patients. BJR Open. 2020;2(1):20200051.

    PubMed  PubMed Central  Google Scholar 

  28. Zhang B, Lee SW, Chen S, et al. Action levels on dose and anatomic variation for adaptive Radiation Therapy using Daily Offline Plan evaluation: preliminary results. Pract Radiat Oncol. 2019;9(1):49–54.

    Article  CAS  PubMed  Google Scholar 

  29. Yap ML, Sun A, Higgins J, et al. Adaptive dose escalation using serial four-dimensional Positron Emission Tomography/Computed tomography scans during Radiotherapy for locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol). 2016;28(12):e199–e205.

    Article  CAS  PubMed  Google Scholar 

  30. Teo TP, Ahmed SB, Kawalec P, et al. Feasibility of predicting tumor motion using online data acquired during treatment and a generalized neural network optimized with offline patient tumor trajectories. Med Phys. 2018;45(2):830–45.

    Article  PubMed  Google Scholar 

  31. Thorwarth D, Low DA. Technical Challenges of Real-Time adaptive MR-Guided Radiotherapy. Front Oncol. 2021;11:634507.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Muurholm CG, Ravkilde T, Skouboe S, et al. Real-time dose-guidance in radiotherapy: Proof of principle. Radiother Oncol. 2021;164:175–82.

    Article  PubMed  Google Scholar 

  33. Keall P, Poulsen P, Booth JT. See, think, and Act: real-time adaptive radiotherapy. Semin Radiat Oncol. 2019;29(3):228–35.

    Article  PubMed  Google Scholar 

  34. Mann P, Witte M, Mercea P, et al. Feasibility of markerless fluoroscopic real-time tumor detection for adaptive radiotherapy: development and end-to-end testing. Phys Med Biol. 2020;65(11):115002.

    Article  CAS  PubMed  Google Scholar 

  35. Ayyalusamy A, Vellaiyan S, Shanmugam S, et al. Feasibility of offline head & neck adaptive radiotherapy using deformed planning CT electron density mapping on weekly cone beam computed tomography. Br J Radiol. 2017;90(1069):20160420.

    Article  PubMed  Google Scholar 

  36. Veiga C, McClelland J, Moinuddin S, et al. Toward adaptive radiotherapy for head and neck patients: feasibility study on using CT-to-CBCT deformable registration for “dose of the day” calculations. Med Phys. 2014;41(3):031703.

    Article  PubMed  Google Scholar 

  37. Klopp AH, Moughan J, Portelance L, et al. Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer. Int J Radiat Oncol Biol Phys. 2013;86(1):83–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wang W, Liu X, Meng Q, et al. Prophylactic extended-field irradiation for patients with cervical Cancer treated with concurrent chemoradiotherapy: a propensity-score matching analysis. Int J Gynecol Cancer. 2018;28(8):1584–91.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Taylor A, Rockall AG, Reznek RH, et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2005;63(5):1604–12.

    Article  PubMed  Google Scholar 

  40. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med. 2004;45(9):1509–18.

    PubMed  Google Scholar 

  41. Small W Jr, Mell LK, Anderson P, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):428–34.

    Article  PubMed  Google Scholar 

  42. Lim K, Small W Jr, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79(2):348–55.

    Article  PubMed  Google Scholar 

  43. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359–73.

    Article  PubMed  Google Scholar 

  44. Wu Y, Cao R, Hu L, et al. Development and validation of dynamic intensity modulated Accurate Radiotherapy System KylinRay-IMRT. Zhongguo Yi Liao Qi Xie Za Zhi. 2018;42(1):7–10. Chinese.

    PubMed  Google Scholar 

  45. Tanderup K, Georg D, Pötter R, et al. Adaptive management of cervical cancer radiotherapy. Semin Radiat Oncol. 2010r;20(2):121–9.

    Article  PubMed  Google Scholar 

  46. Jadon R, Pembroke CA, Hanna CL, et al. A systematic review of organ motion and image-guided strategies in external beam radiotherapy for cervical cancer. Clin Oncol (R Coll Radiol). 2014;26(4):185–96.

    Article  CAS  PubMed  Google Scholar 

  47. Hanfmann B, Engels M, Dörr W. Radiation-induced impairment of urinary bladder function. Assessment of micturition volumes. Strahlenther Onkol. 1998;174(Suppl 3):96–8.

    PubMed  Google Scholar 

  48. Agur AMR, Dalley AF. Grant’s Atlas of Anatomy. 12th ed. [M]. Philadelphia: Lippincott,Williams Wilkins Press, 2009.

  49. National Health Commission Of The People’s Republic Of China. National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version). Chin J Cancer Res. 2022;34(3):256–69.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Mayr NA, Taoka T, Yuh WT, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2002;52(1):14–22.

    Article  PubMed  Google Scholar 

  51. Arnesen MR, Hellebust TP, Malinen E. Impact of dose escalation and adaptive radiotherapy for cervical cancers on tumour shrinkage-a modelling study. Phys Med Biol. 2017;62(6):N107–19.

    Article  PubMed  Google Scholar 

  52. Buijs M, Bloemers MCWM, Remeijer P. Impact of a fiducial marker based ART strategy on margins in postoperative IMRT of gynecological tumors. Radiother Oncol. 2021;158:1–6.

    Article  PubMed  Google Scholar 

  53. Sun R, Mazeron R, Chargari C, et al. CTV to PTV in cervical cancer: from static margins to adaptive radiotherapy. Cancer Radiother. 2016;20(6–7):622–8.

    Article  CAS  PubMed  Google Scholar 

  54. Portelance L, Corradini S, Erickson B, et al. Online magnetic resonance-guided Radiotherapy (oMRgRT) for gynecological cancers. Front Oncol. 2021;11:628131.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Ecker S, Zimmermann L, Heilemann G, et al. Neural network-assisted automated image registration for MRI-guided adaptive brachytherapy in cervical cancer. Z Med Phys. 2022;12:0939. -3889(22)00057 – 5.

    Google Scholar 

  56. Wang B, Hu W, Shan G, et al. Estimating the accumulative dose uncertainty for intracavitary and interstitial brachytherapy. Biomed Eng Online. 2021;20(1):106.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Bondar ML, Hoogeman MS, Mens JW, et al. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans. Int J Radiat Oncol Biol Phys. 2012;83(5):1617–23.

    Article  CAS  PubMed  Google Scholar 

  58. Heijkoop ST, Langerak TR, Quint S, et al. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT. Int J Radiat Oncol Biol Phys. 2014;90(3):673–9.

    Article  PubMed  Google Scholar 

  59. Yu L, Zhao J, Zhang Z, et al. Commissioning of and preliminary experience with a new fully integrated computed tomography linac. J Appl Clin Med Phys. 2021;22(7):208–23.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Thirion JP. Image matching as a diffusion process: an analogy with Maxwell’s demons. Med Image Anal. 1998;2(3):243–60.

    Article  CAS  PubMed  Google Scholar 

  61. Zwan BJ, Caillet V, Booth JT, et al. Toward real-time verification for MLC tracking treatments using time-resolved EPID imaging. Med Phys. 2021;48(3):953–64.

    Article  PubMed  Google Scholar 

  62. McCowan PM, Van Uytven E, Van Beek T, et al. An in vivo dose verification method for SBRT-VMAT delivery using the EPID. Med Phys. 2015;42(12):6955–63.

    Article  CAS  PubMed  Google Scholar 

  63. Van Elmpt W, Nijsten S, Petit S, et al. 3D in vivo dosimetry using megavoltage cone-beam CT and EPID dosimetry. Int J Radiat Oncol Biol Phys. 2009;73(5):1580–7.

    Article  PubMed  Google Scholar 

  64. Feng B, Yu L, Mo E, et al. Evaluation of Daily CT for EPID-Based transit in vivo Dosimetry. Front Oncol. 2021;11:782263.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Murphy MJ, Balter J, Balter S, et al. The management of imaging dose during image-guided radiotherapy: report of the AAPM Task Group 75. Med Phys. 2007;34(10):4041–63.

    Article  PubMed  Google Scholar 

  66. Steiner E, Stock M, Kostresevic B, et al. Imaging dose assessment for IGRT in particle beam therapy. Radiother Oncol. 2013;109(3):409–13.

    Article  CAS  PubMed  Google Scholar 

  67. Fan J, Cao X, Xue Z, et al. Adversarial Similarity Network for evaluating Image Alignment in Deep Learning based Registration. Med Image Comput Comput Assist Interv. 2018;11070:739–46.

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Thank you to Chunyan Dai, Dong Gao, Tengda Wang and Binghuan Li, engineers from the United Imaging corporation, for providing technological support.

Funding

Applied basic research program, Science & Technology Department of Sichuan Province (2020YJ0451); Introduction Foundation of High-level Talents of the First Affiliated Hospital, Chengdu Medical College (CYFY-GQ22); The Special Project of the First Affiliated Hospital, Chengdu Medical College (CYFY2019ZD03); The Cultivation Project of Key Subjects (oncology department), First Affiliated Hospital, Chengdu Medical College. Wu Jieping Medical Foundation (320.6750.2021-22-17).

Author information

Author notes

  1. Haibo Peng and Jie Zhang contributed equally to this work and share first authorship.

Authors and Affiliations

  1. Oncology Department, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China

    Haibo Peng, Jie Zhang, Ningyue Xu, Yangang Zhou, Huigang Tan & Tao Ren

  2. Key Clinical Specialty of Sichuan Province (Oncology Department), The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China

    Haibo Peng, Jie Zhang & Tao Ren

  3. Clinical Medical School, Chengdu Medical College, Chengdu, 610500, China

    Haibo Peng, Jie Zhang & Tao Ren

Authors
  1. Haibo Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ningyue Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yangang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Huigang Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tao Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

H.P and J.Z designed the study and wrote the main manuscript. J.Z and N.X analyzed the data. N.X and Y.Z prepared Figs. 1 and 2. H.T prepared Figs. 3 and 4; Tables 1 and 2. T.R supervised the research and reviewed the manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Tao Ren.

Ethics declarations

Ethics approval and consent to participate

The Ethics Committee of the First Affiliated Hospital of Chengdu Medical College had approved the study and the corresponding opinion letter NO. was 2022CYFYIRB-BA-Sep04. The informed consent had been obtained from each patient before enrollment and the whole process conformed to the guideline of cervical cancer of American Society for Radiation Oncology (ASTRO). All methods were performed in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, H., Zhang, J., Xu, N. et al. Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation. BMC Cancer 23, 588 (2023). https://doi.org/10.1186/s12885-023-11089-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12885-023-11089-6

Keywords

  • Online adaptive radiotherapy
  • Uterine cervical cancer
  • Image guided radiotherapy
  • In vivo dose verification
  • Dosimetry

BMC Cancer

ISSN: 1471-2407

Contact us